有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-benzyl-N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C17H17N3O3S2 |
|
—— | N-[(2-methylphenyl)methyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C14H15N3OS |
|
—— | N-(2-methylbutan-2-yl)-2-pyrimidin-2-ylsulfanylacetamide | —— | C11H17N3OS |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-N-(2-methoxyethyl)-2-pyrimidin-2-ylsulfanylacetamide | —— | C13H19N3O4S2 |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-N-methyl-2-pyrimidin-2-ylsulfanylacetamide | —— | C16H20N4OS |
|
—— | [2-[2-(4-Bromophenyl)sulfanylethylamino]-2-oxoethyl] cyclopentanecarboxylate | —— | C16H20BrNO3S |
|
—— | N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-cyclopentyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C19H28N6O3S |
|
—— | 3-[(1-Methylimidazol-2-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole | —— | C14H13N3OS |
|
—— | N-(1-adamantyl)-N-(2-cyanoethyl)-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C19H26N4OS |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-N-methyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C16H22N4OS |
|
—— | 2-[(2-Chlorophenyl)sulfanylmethyl]-5-(3-methylphenyl)-1,3,4-oxadiazole | —— | C16H13ClN2OS |
|
—— | 2-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-N-methyl-N-(thiophen-3-ylmethyl)acetamide | —— | C10H12N4OS3 |
|
—— | N-benzyl-2-(2-chlorophenyl)sulfanyl-N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]acetamide | —— | C19H18ClNO3S2 |
|
—— | 2-(2-chlorophenyl)sulfanyl-N-[2-(2-fluorophenyl)ethyl]acetamide | —— | C16H15ClFNOS |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[2-(4-bromophenyl)sulfanylethyl]acetamide | —— | C12H13BrN4OS3 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(4-methylphenyl)methyl]-N-propylacetamide | —— | C15H20N4OS2 |
|
—— | 2-(2-chlorophenyl)sulfanyl-N-[(S)-phenyl(thiophen-2-yl)methyl]acetamide | —— | C19H16ClNOS2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(2R)-butan-2-yl]-N-[(2S)-butan-2-yl]acetamide | —— | C12H22N4OS2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1R)-1-cyclopropylethyl]acetamide | —— | C9H14N4OS2 |
|
—— | 5-(((5-(Furan-2-yl)isoxazol-3-yl)methyl)thio)-1,3,4-thiadiazol-2-amine | —— | C10H8N4O2S2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methyl-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C11H14N4OS3 |
|
—— | (Z)-3-amino-2-[2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]but-2-enenitrile | —— | C15H14N4O2S |
|
—— | 1,3-Dichloro-2-(4-methylsulfonyl-2-nitrophenyl)sulfanylbenzene | —— | C13H9Cl2NO4S2 |
|
—— | (2S)-1-[3-fluoro-4-(1-methylpyrazol-4-yl)sulfanylphenyl]butan-2-amine | —— | C14H18FN3S |
|
—— | 1,3,5-Trimethyl-2-(4-methylsulfonyl-2-nitrophenyl)sulfanylbenzene | —— | C16H17NO4S2 |
|
—— | (2S)-1-(5-fluoro-2-pyrimidin-4-ylsulfanylphenyl)butan-2-amine | —— | C14H16FN3S |
|
—— | (2R)-1-[2-(1-methylpyrazol-4-yl)sulfanylphenyl]propan-2-amine | —— | C13H17N3S |
|
—— | (2R)-1-[3-fluoro-4-(1-methylpyrazol-4-yl)sulfanylphenyl]butan-2-amine | —— | C14H18FN3S |
|
—— | (2R)-1-(5-fluoro-2-pyrimidin-4-ylsulfanylphenyl)butan-2-amine | —— | C14H16FN3S |
|
—— | (2S)-1-[2-(1-methylpyrazol-4-yl)sulfanylphenyl]propan-2-amine | —— | C13H17N3S |
|
—— | (2R)-1-(1,3-dimethyl-5-pyrimidin-4-ylsulfanylpyrazol-4-yl)propan-2-amine | —— | C12H17N5S |
|
—— | (2S)-1-(1,3-dimethyl-5-pyrimidin-4-ylsulfanylpyrazol-4-yl)propan-2-amine | —— | C12H17N5S |
|
—— | (1S)-1-(4-methylsulfanylphenyl)-N-[2-(1,3-thiazol-4-yl)ethyl]ethanamine | —— | C14H18N2S2 |
|
—— | 4-Chloro-5-(2-fluorophenyl)sulfanyl-2-phenylpyridazin-3-one | —— | C16H10ClFN2OS |
|
—— | (2S)-1-(4-pyrimidin-4-ylsulfanylphenyl)propan-2-amine | —— | C13H15N3S |
|
—— | (1R)-1-(4-methylsulfanylphenyl)-N-[2-(1,3-thiazol-4-yl)ethyl]ethanamine | —— | C14H18N2S2 |
|
—— | 4-(2-fluorophenyl)sulfanyl-N-[(2R)-1-methoxypropan-2-yl]-3-nitrobenzenesulfonamide | —— | C16H17FN2O5S2 |
|
—— | (2S)-1-(4-pyrimidin-4-ylsulfanylphenyl)butan-2-amine | —— | C14H17N3S |
|
—— | (2R)-1-(4-pyrimidin-4-ylsulfanylphenyl)butan-2-amine | —— | C14H17N3S |
|
—— | N,N-diethyl-4-(2-fluorophenyl)sulfanyl-3-nitrobenzenesulfonamide | —— | C16H17FN2O4S2 |
|
—— | 4-[(3S)-1-[[(1S)-cyclohex-3-en-1-yl]methyl]piperidin-3-yl]-2-(2-pyrrolidin-1-ylethylsulfanyl)pyrimidine | —— | C22H34N4S |
|
—— | 1-[4-(2-Fluorophenyl)sulfanyl-3-nitrophenyl]sulfonyl-4-methylpiperazin-4-ium | —— | C17H19FN3O4S2+ |
|
—— | (2S)-1-[4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-3-methylphenyl]propan-2-amine | —— | C14H20N4S |
|
—— | (2R)-1-[5-(cyclopentylmethylsulfanyl)-1,3-dimethylpyrazol-4-yl]butan-2-amine | —— | C15H27N3S |
|
—— | (2S)-1-[4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-3-fluorophenyl]propan-2-amine | —— | C13H17FN4S |
|
—— | (2R)-1-[4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-3-methylphenyl]propan-2-amine | —— | C14H20N4S |
|
—— | (2R)-1-(5-fluoro-2-pyrazin-2-ylsulfanylphenyl)butan-2-amine | —— | C14H16FN3S |
|
—— | (2S)-1-[5-(3-methoxypropylsulfanyl)-1,3-dimethylpyrazol-4-yl]propan-2-amine | —— | C12H23N3OS |
|
—— | (2S)-1-[6-(oxan-4-ylsulfanyl)imidazo[2,1-b][1,3]thiazol-5-yl]propan-2-amine | —— | C13H19N3OS2 |
|
—— | (2R)-1-[5-(3-methoxypropylsulfanyl)-1,3-dimethylpyrazol-4-yl]propan-2-amine | —— | C12H23N3OS |
|